The SPHERAZO brand, founded in 2013 (Switzerland), from 19 sister brands and 2214 competing brands. SPHERAZO is a brand of BASILEA PHARMA, listed on the stock exchange of Zurich. Its International Securities Identification Number (ISIN) is CH0011432447. SPHERAZO belongs to the Biotechnology business sector.

SPHERAZO is a brand of BASILEA PHARMA (BSLN) Share price

International deposit : 2013 Business sector Biotechnology

Share price and profitability of the share BASILEA PHARMA (SPHERAZO)

Buy BASILEA PHARMA share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 41.25

Portfolio valuation
BASILEA PHARMA (SPHERAZO) over 5 years* CHF 37.88

Stock market history BASILEA PHARMA (SPHERAZO)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
BASILEA PHARMA

See more brands of BASILEA PHARMA

Rival brands
SPHERAZO

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS